Correlation Between Sonoma Pharmaceuticals and Agile Thrpe

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sonoma Pharmaceuticals and Agile Thrpe at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonoma Pharmaceuticals and Agile Thrpe into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sonoma Pharmaceuticals and Agile Thrpe, you can compare the effects of market volatilities on Sonoma Pharmaceuticals and Agile Thrpe and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonoma Pharmaceuticals with a short position of Agile Thrpe. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonoma Pharmaceuticals and Agile Thrpe.

Diversification Opportunities for Sonoma Pharmaceuticals and Agile Thrpe

0.63
  Correlation Coefficient

Poor diversification

The 3 months correlation between Sonoma and Agile is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Sonoma Pharmaceuticals and Agile Thrpe in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agile Thrpe and Sonoma Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonoma Pharmaceuticals are associated (or correlated) with Agile Thrpe. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agile Thrpe has no effect on the direction of Sonoma Pharmaceuticals i.e., Sonoma Pharmaceuticals and Agile Thrpe go up and down completely randomly.

Pair Corralation between Sonoma Pharmaceuticals and Agile Thrpe

Given the investment horizon of 90 days Sonoma Pharmaceuticals is expected to generate 2.6 times more return on investment than Agile Thrpe. However, Sonoma Pharmaceuticals is 2.6 times more volatile than Agile Thrpe. It trades about -0.02 of its potential returns per unit of risk. Agile Thrpe is currently generating about -0.22 per unit of risk. If you would invest  2,200  in Sonoma Pharmaceuticals on August 28, 2024 and sell it today you would lose (1,907) from holding Sonoma Pharmaceuticals or give up 86.68% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy4.24%
ValuesDaily Returns

Sonoma Pharmaceuticals  vs.  Agile Thrpe

 Performance 
       Timeline  
Sonoma Pharmaceuticals 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Sonoma Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat inconsistent basic indicators, Sonoma Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Agile Thrpe 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Agile Thrpe has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Agile Thrpe is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Sonoma Pharmaceuticals and Agile Thrpe Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sonoma Pharmaceuticals and Agile Thrpe

The main advantage of trading using opposite Sonoma Pharmaceuticals and Agile Thrpe positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonoma Pharmaceuticals position performs unexpectedly, Agile Thrpe can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agile Thrpe will offset losses from the drop in Agile Thrpe's long position.
The idea behind Sonoma Pharmaceuticals and Agile Thrpe pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments